NCT06588517View on ClinicalTrials.gov

Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

April 19, 2024

Study Completion Date

April 27, 2024

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Pirfenidone Modified-Release Tablets

take the tablet under fed condition, 1 tablet at a time, once a day.

DRUG

Pirfenidone Tablets

ake the tablet under fed condition, 1 tablet at a time, three times a day.

Trial Locations (1)

266000

The Affiliated Hospital of Qingdao University, Qingdao

Sponsors
All Listed Sponsors
collaborator

Shanghai ShouYan Clinical Development Co.,Ltd.

UNKNOWN

lead

Overseas Pharmaceuticals, Ltd.

INDUSTRY

NCT06588517 - Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions | Biotech Hunter | Biotech Hunter